On July 19, 2022, the Centers for Disease Control and Prevention (CDC) authorized the emergency use of Novavax, a protein-based COVID-19 vaccine, as another primary series option for adults ages 18 years and older. In this Q&A with Cindy Williams, Chief Pharmacy Officer for Riverside, we learn more about Novavax and its approval as the fourth COVID-19 vaccine available in the United States.
Learn more about the COVID-19 vaccine options by visiting [ Ссылка ]
-Follow us-
Website: [ Ссылка ]
Facebook: [ Ссылка ]
Instagram: @RiversideHealth
Twitter @RiversideHealth
